Investors & News - AADI Bioscience - Page 12

Navigation

Company
Our Science
Our Medicine
- Our Medicine
- Advanced Malignant PEComa
Pipeline
Patients
Investors & News
Contact Us

Latest News

0 0

by / / Uncategorized

Previous
1
...
5
6
7
8
9
10
11
12
Next

Recent Articles

Baiteng Zhao, PhD
A Phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
Antitumor activity of nab-sirolimus versus mTOR inhibitors temsirolimus, sirolimus, and everolimus in A549 NSCLC xenografts
Evaluation of nab-sirolimus in combination with fulvestrant or PI3K pathway inhibitors to overcome resistance in breast cancer cell lines
Correlation of nab-sirolimus tumor drug levels and improved tumor suppression in KRAS G12C non-small cell lung cancer xenografts treated with nab-sirolimus in combination with KRAS inhibitors

Home
Leadership
Pipeline
Patients
Contact
Careers

Terms & Conditions
Privacy